NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
Le, Yong, Kan, Anna, Li, Qi-Jiong, He, Min-Ke, Chen, Hai-Long, Shi, MingVolume:
19
Journal:
Cancer Cell International
DOI:
10.1186/s12935-019-0949-0
Date:
December, 2019
File:
PDF, 2.03 MB
2019